Stock Research: Apollo Hospitals Enterprise

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Apollo Hospitals Enterprise

NSEI:APOLLOHOSP INE437A01024
50
  • Value
    16
  • Growth
    100
  • Safety
    Safety
    9
  • Combined
    23
  • Sentiment
    85
  • 360° View
    360° View
    50
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Apollo Hospitals Enterprise Limited is an integrated healthcare company providing hospital services, pharmacy sales, and wellness products. It operates in Healthcare Services, Retail Health and Diagnostics (clinics and diagnostics), Digital Health and Pharmacy Distribution (pharmaceuticals, FMCG, private label products via digital platform), and Others. The company has approximately 10,000+ beds across 73 hospitals, 5000+ pharmacies, 378+ clinics and diagnostic centers, and 200 telemedicine centers. In the last fiscal year, the company had a market cap of $12298 million, profits of $1227 million, and revenue of $2550 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 50 (better than 50% compared with alternatives), overall professional sentiment and financial characteristics for the stock Apollo Hospitals Enterprise are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Apollo Hospitals Enterprise. The consolidated Growth Rank has a good rank of 100, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 100% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 85, which means that professional investors are more optimistic about the stock than for 85% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 9, which means that the share price of Apollo Hospitals Enterprise is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 91% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 16, which means that the company has a financing structure that is riskier than those of 84% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
9 17 8 11
Growth
100 91 87 95
Safety
Safety
16 14 24 12
Sentiment
85 55 82 59
360° View
360° View
50 31 48 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
91 81 82 87
Opinions Change
43 33 54 50
Pro Holdings
n/a 32 42 12
Market Pulse
84 84 74 55
Sentiment
85 55 82 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
9 17 8 11
Growth
100 91 87 95
Safety Safety
16 14 24 12
Combined
23 20 23 16
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
9 13 5 7
Price vs. Earnings (P/E)
43 39 42 36
Price vs. Book (P/B)
7 5 5 9
Dividend Yield
20 28 24 25
Value
9 17 8 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
96 83 87 70
Profit Growth
85 73 61 98
Capital Growth
79 93 98 36
Stock Returns
75 41 51 97
Growth
100 91 87 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
16 20 28 14
Refinancing
25 17 21 25
Liquidity
36 51 46 25
Safety Safety
16 14 24 12

Similar Stocks

Discover high‑ranked alternatives to Apollo Hospitals Enterprise and broaden your portfolio horizons.

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Maruti Suzuki

NSEI:MARUTI
Country: India
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Dr. Reddy's

BSE:500124
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

L&T Finance Holdings

BSE:533519
Country: India
Industry: Other Financial Services
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.